Pyrexia, commonly referred to as fever, is a frequently encountered symptom in clinical practice. It is a complex physiological response to disease processes, often indicating the presence of an underlying infection. This article provides a comprehensive guide to understanding and managing fever in a clinical setting.
Pyrexia is characterized by an elevation in body temperature above the normal range, typically triggered by the release of pyrogens from immune cells. Pyrogens stimulate the hypothalamus to increase the body's set point temperature, resulting in fever. It is crucial to note that fever is a symptom and not a disease, serving as a protective response to help the body fight off pathogens.
Accurate assessment of pyrexia involves a thorough patient history, physical examination, and appropriate investigations. The history should focus on potential sources of infection, recent travel, medication use, and immunization status. Physical examination should look for localized signs of infection and systemic signs of inflammation. Investigations may include complete blood count, blood cultures, radiological imaging, and other specific tests based on clinical suspicion.
The management of pyrexia primarily involves treating the underlying cause. Antipyretics can be used to alleviate discomfort, but they do not treat the cause of the fever. Antibiotics, antivirals, or antifungals may be prescribed if an infection is identified. In cases where the cause is non-infectious, targeted therapies may be required. Patient education about the nature of fever and reassurance is an essential aspect of management.
Pyrexia is a common clinical symptom with a wide range of potential causes. Accurate assessment and diagnosis are key to identifying the underlying cause and guiding management. While fever can cause discomfort, it is a critical part of the body's defense mechanism. As clinicians, our role is to support this natural process while addressing the root cause and ensuring patient comfort and understanding.
1.
Research uncovers hidden Australian skin cancer epidemic
2.
What Could This Exploratory 5-Year Survival Data in Adjuvant NSCLC Treatment Mean?
3.
The clinical trial of ENZAMET shows promise as a treatment for prostate cancer.
4.
Cancer Vaccines' Emergence; More Focus on Side Effects; A Nudge for Exercise.
5.
Using MRD Status to Deescalate Multiple Myeloma Therapy
1.
Understanding Purpura Fulminans: Causes, Symptoms and Treatment Options
2.
The Importance of Maintaining Normal Calcium Levels in Your Body
3.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
4.
Metabolic Symbiosis Within the Tumor Niche: Mechanisms, Clinical Implications, and Therapeutic Opportunities
5.
A Comprehensive Guide to Carcinoma in Situ: Types, Risks, and Preventive Measures
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
2.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
3.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
4.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
5.
Latest Advances in Hematology
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation